Clinical trial

OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for…

NCT02522871 · TransMedics, Industry · Completed

Key facts

NCT number NCT02522871
Title OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for Transplantation
Official title International Randomized Trial to Evaluate The Effectiveness of The Portable Organ Care System (OCS™) Liver For Preserving and Assessing Donor Livers for Transplantation (OCS Liver PROTECT Trial)
Acronym PROTECT
Lead sponsor TransMedics, Industry
Status Completed
Study type Interventional
Conditions Liver Transplantation, Liver Preservation for Transplant
Intervention type Device, Other
Interventions OCS™ Liver System, Control
Enrollment 300
Start date Jan 24, 2016
Primary completion Oct 22, 2019
Completion Nov 5, 2021
First posted Aug 13, 2015
Last update posted Jun 29, 2023
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies